Document is current
Any future updates will be listed below
-
Authors
Zwaans, Bernadette M. M.
Lamb, Laura E.
Bartolone, Sarah
Nicolai, Heinz E.
Chancellor, Michael B.
Klaudia, Stangel-Wójcikiewicz
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK114334)
Comprehensive Cancer Center, University of Michigan
- License Information
-
More Information
Article History
Received: 13 June 2018
Accepted: 17 August 2018
First Online: 21 August 2018
Compliance with ethical standards
:
: Dr. Chancellor is the founder and Chief Scientific Officer of Lipella Pharmaceuticals, Inc. The remaining authors declare that they have no relevant conflicts of interest.
